Premixed i.v. admixtures for reducing costs and labor time in a home infusion company

被引：2
|
作者：
Petroff, BJ [1 ]
机构：
[1] Apria Healthcare, Ann Arbor, MI 48108 USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2000年 / 57卷 / 04期
关键词：
D O I：
10.1093/ajhp/57.4.390
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [41] Association between continuous peripheral i.v. infusion of 3% sodium chloride injection and phlebitis in adults
    Meng, Lina
    Nguyen, Cherwyn M.
    Patel, Samit
    Mlynash, Michael
    Caulfield, Anna Finley
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (05) : 284 - 291
  • [42] Clinical pharmacology and pharmacogenetics of flavopiridol 1-h i.v. infusion in patients with refractory neoplasms
    Zhai, SP
    Sausville, EA
    Senderowicz, AM
    Ando, Y
    Headlee, D
    Messmann, RA
    Arbuck, S
    Murgo, AJ
    Melillo, G
    Fuse, E
    Figg, WD
    ANTI-CANCER DRUGS, 2003, 14 (02) : 125 - 135
  • [43] Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2′-deoxyuridine and leucovorin
    Garcia, AA
    Muggia, FM
    Spears, CP
    Jeffers, S
    Silberman, H
    Pujari, M
    Koda, RT
    ANTI-CANCER DRUGS, 2001, 12 (06) : 505 - 511
  • [44] Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients
    Zambetti, M
    Demicheli, R
    DeCandis, D
    Antonelli, G
    Giacobone, A
    Terenziani, M
    Laffranchi, A
    Garbagnati, E
    Biasi, S
    Bonadonna, G
    BREAST CANCER RESEARCH AND TREATMENT, 1997, 44 (03) : 255 - 260
  • [45] Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: A possible role for platelet activation
    DiPerri, T
    Pasini, FL
    Puccetti, T
    Messa, GL
    Bianciardi, G
    LaPlaca, G
    Blardi, P
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1211 - P1211
  • [46] Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients
    M. Zambetti
    R. Demicheli
    D. De Candis
    G. Antonelli
    A. Giacobone
    M. Terenziani
    A. Laffranchi
    F. Garbagnati
    S. Biasi
    G. Bonadonna
    Breast Cancer Research and Treatment, 1997, 44 : 255 - 260
  • [47] Twice daily i.v. bolus tacrolimus infusion for GVHD prophylaxis in children undergoing stem cell transplantation
    Skeens, M.
    Pai, V.
    Garee, A.
    Termuhlen, A. M.
    Bajwa, R. P. S.
    Gross, T. G.
    Soni, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 (11) : 1415 - 1418
  • [48] Twice daily i.v. bolus tacrolimus infusion for GVHD prophylaxis in children undergoing stem cell transplantation
    M Skeens
    V Pai
    A Garee
    A M Termuhlen
    R P S Bajwa
    T G Gross
    S Soni
    Bone Marrow Transplantation, 2012, 47 : 1415 - 1418
  • [49] Multicenter study to evaluate the benefits of technology-assisted workflow on i.v. room efficiency, costs, and safety
    Eckel, Stephen F.
    Higgins, Jordyn P.
    Hess, Elizabeth
    Cerbone, Thomas
    Civiello, Jennifer B.
    Conley, Christian
    Jafari, Nilofar
    Shah, Shailly
    Speth, Stephen L.
    Thornton, Lynn
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (12) : 895 - 901
  • [50] Time to move the goalposts? Do we need new targets for developing i.v. anaesthetics?
    Sneyd, J. R.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 117 (06) : 684 - 687
12345